Published in
Elsevier, International Immunopharmacology, (107), p. 108632, 2022
DOI: 10.1016/j.intimp.2022.108632
Links
Tools
Epoxymicheliolide inhibits osteoclastogenesis and resists OVX-induced osteoporosis by suppressing ERK1/2 and NFATc1 signaling
Journal article published in 2022 by
Feng Long,
Runfeng Chen,
Yuangang Su,
Jiamin Liang,
Yansi Xian,
Fan Yang,
Haoyu Lian,
Jiake Xu,
Jinmin Zhao,
Qian Liu
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 